Sinoway Industrial Co., Ltd.

Octreotide Acetate 83150-76-9 Octreotide Acetate 83150-76-9

Octreotide Acetate 83150-76-9
Related Products
  • L-Glutathione Reduced (GSH) 70-18-8

    L-Glutathione ReducedBasic information of L-Glutathione Reduced:Product name: L-Glutathione ReducedMolecular Formula : C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc...

  • Copper Peptide (GHK)2-CU 49557-75-7

    Copper peptide GHK-CuBasic information of copper peptide GHK-Cu :Product Name(GHK)2-Cu(Copper Peptide)SynonymsGHK-Cu (Copper peptide)CAS #49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2...

  • Isoflavones in Soy 574-12-9

    Soybean Extract1.Basic information of Soybean Extract:Product name: Soybean ExtractSource: glycine maxUsed part: germ/bean pulpSpec.: total soy isoflavone 40%, 80% by HPLCNameSoybean Extract PowderTyp...

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).

MORE_DETAIL Octreotide Acetate 83150-76-9

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//